[PDF] Top 20 Analyzing SIAH1 and SIAH2 as oncogenic factors in oral squamous cell carcinoma

... 投稿摘要表格（正本） Analyzing SIAH1 and SIAH2 as oncogenic factors in oral squamous cell carcinoma 林育盛 楊嘉銘 周庭瑜 林如華 Yu-Sheng Lin, ... See full document

... Science and Technology, College of Life Sciences, China Medical University, Taichung, Taiwan Backgrounds: The mortality of oral squamous cell carcinoma (OSCC) is one of the ten leading ... See full document

... of oral squamous cell carcinoma (OSCC) is one of the ten leading causes of cancer deaths in ...such as betel quid chewing, tobacco smoking and alcohol drinking have been ... See full document

... expression and functional significance of seven in absentia homologues 2 (SIAH2), an E3 ubiquitin ligase, in oral squamous cell carcinoma ...Materials ... See full document

... TERT, and TFPI2) with great potential for detecting ...role as biomarkers. EPHA7, 12 FGF3, 13 and NPY 14, 15 are related to tumor progression, GAS7 controls neuritogenesis, 16 ASCL1 ... See full document

... of oral squamous cell carcinoma (OSCC) is one of the ten leading causes of cancer deaths in ...such as betel quid chewing, tobacco smoking and alcohol drinking have been ... See full document

... Introduction Oral cancer is the eighth most common cancer worldwide and the third most common type of cancer in South Asian ...of oral and pharyngeal cancers are diagnosed ...incidence, ... See full document

... involved in the regulation of let-7 g and lectin- like oxidized LDL receptor-1 (LOX-1) [44]; let-7 and Fas [45]; ZEB1-SIP and the miR-200 family ...miR-99a and ... See full document

... indices in tissues signifi- cantly correlate with OSCCs of larger size, lymph node metastasis, and more advanced clinical stage 15 ; and C1772T could provide HIF- 1 a with higher ...were ... See full document

... Introduction Oral leukoplakia, oral submucous fibrosis, and erythroplakia are the three major forms of oral premalignant lesions (OPLs) and oral leukoplakia accounts for 85% of ... See full document

... recurrence and invasive tumor behavior. (6-10) The treatment of choice in buccal SCC is conventionally a combination of surgery, radiotherapy, and ...prognostic factors has become an important ... See full document

... In addition, we analyzed the expression of SIAH1 mRNA level in OSCC cell lines and clinical samples by Q-PCR.. The result indicates that the expression of SIAH1 mRNA in CA922 and OECM1 w[r] ... See full document

... We had detected the whole genome of ten oral patients by aCGH (Array-based Comparative Genomic Hybridization) and found that 80% of oral cancer patients had the situation of SIAH2 copy n[r] ... See full document

... Abstract 2 β-Naphthoflavone (-NF), a ligand of the aryl hydrocarbon receptor, has been shown 3 to possess anti-oxidative ...anti-oxidative and 4 anti-inflammatory potential of -NF in human ... See full document

... LOX overexpression OSCC cells showed higher and equivalent numbers of LOX activity in both clones.. Proliferating cell nuclear antigen (PCNA).[r] ... See full document

... al., and further defined by Bryne et al. 15,18 POI type 1 represents tumour invasion in a broad pushing manner with a smooth ...type 2 represents tumour invasion with broad pushing ‘fingers’, ... See full document

... Materials and Methods. Comparative genomic hybridization and real-time PCR were performed to examine the amplification of Siah1 gene in clinical specimens of OSCC ...of ... See full document

... expression and progression of HNSCC was ...recurrence, and survival prognosis using immunohistochemical analysis of primary HNSCC patient tumour ...Tid1 in HNSCC cells was shown to ... See full document

... promoter in oral tissue specimens was evaluated by bisulfite sequencing assay, quantitative methylation-specific PCR, and pyrosequencing ...differences in methylation levels among the groups ... See full document

... growth in vivo. Hinokitiol is used as a food additive for preservative purposes, and the suggested concentration is 125 ppm (762 µM) per day, which is higher than the dose used in the present ... See full document